AR026371A1 - Nueva formulacion, uso y metodo - Google Patents

Nueva formulacion, uso y metodo

Info

Publication number
AR026371A1
AR026371A1 ARP000105838A ARP000105838A AR026371A1 AR 026371 A1 AR026371 A1 AR 026371A1 AR P000105838 A ARP000105838 A AR P000105838A AR P000105838 A ARP000105838 A AR P000105838A AR 026371 A1 AR026371 A1 AR 026371A1
Authority
AR
Argentina
Prior art keywords
conditions
prodrugs
metabolites
optionally comprises
comprises salts
Prior art date
Application number
ARP000105838A
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of AR026371A1 publication Critical patent/AR026371A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un dispositivo para la administracion transdérmica de reboxetina, que opcionalmente comprende sales, prodrogas y metabolitos de los mismos para el uso dereboxetina que opcionalmente comprende sales, prodrogas y metabolitos de los mismos; un método pa ra la fabricacion de un medicamento a ser administradotransdermicamente; y métodos para tratar depresion, afecciones adictivas y síndromes de abstinencia, afecciones adaptativas, afecciones mentales y asociadascon la edad, anorexia nerviosa, apatía, afecciones deficitarias en la atencion debido a dolencias médicas generales, afecciones de déficit en la atenciondebido a hiperactividad, afecciones bipolares, bulimia nerviosa, síndrome de fátiga cronica, afecciones de conducta, afecciones ciclotími cas, depresion,afecciones distímicas, fibromialgia, y otras afecciones somatoformes, incontinencia por estrés, afecciones de ansiedad generalizada, afecciones por inhalacion,afecciones por intoxicacion, obesidad, afecciones obsesivo-compulsivas y afe cciones relacionadas con este espectro, afecciones de oposicion desafiante,afecciones de pánico, neuropatía periférica, afecciones de estrés postrauma, afecciones de disforias premestruales, afecciones psicoticas, afeccionesemocionales estacionales, afecciones del sueno, fobia social, afecciones específicas del desarrollo e inhibicion selectiva de la recaptacion de serotonina(SSRI) y síndrome de agotamiento, y síntomas asociados con estas dolencias, y/o para obtener un efecto antireserpina y/o i nhibitorio de la recaptacion denor-adrenalina, mediante la administracion transdérmica de reboxetina, que opcionalmente comprende sales, prodrogas o metabolitos de los mismos.
ARP000105838A 1999-12-23 2000-11-06 Nueva formulacion, uso y metodo AR026371A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904750A SE9904750D0 (sv) 1999-12-23 1999-12-23 New formulation, use and method

Publications (1)

Publication Number Publication Date
AR026371A1 true AR026371A1 (es) 2003-02-05

Family

ID=20418276

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105838A AR026371A1 (es) 1999-12-23 2000-11-06 Nueva formulacion, uso y metodo

Country Status (7)

Country Link
EP (1) EP1244431A1 (es)
AR (1) AR026371A1 (es)
AU (1) AU1068101A (es)
MY (1) MY133485A (es)
PE (1) PE20011024A1 (es)
SE (1) SE9904750D0 (es)
WO (1) WO2001047503A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1629843A3 (en) * 1999-07-01 2006-03-15 Pharmacia & Upjohn Company LLC Reboxetine for treating chronic fatigue syndrome
DK1459750T3 (da) 1999-07-01 2005-08-15 Pharmacia & Upjohn Co Llc (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
TWI754702B (zh) 2016-12-28 2022-02-11 德商Ｕｃｂ製藥有限公司 （氮雜）吲哚－和苯並呋喃－３－磺醯胺類
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
TW202016088A (zh) 2018-06-19 2020-05-01 德商Ｕｃｂ製藥有限公司 吡啶基及吡基-（氮）吲哚磺醯胺
EP3584244A1 (en) 2018-06-20 2019-12-25 UCB Pharma GmbH Substituted alkoxypyridinyl indolsulfonamides
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
CN113993845A (zh) 2019-06-17 2022-01-28 优时比制药有限公司 作为治疗cns障碍例如多发性硬化的gpr17调节剂的n-(苯基)-吲哚-3-磺酰胺衍生物和相关化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5155198A (en) * 1997-08-28 1999-03-22 Robert Murdock Method and composition for transdermal administration of pharmacologic agent

Also Published As

Publication number Publication date
EP1244431A1 (en) 2002-10-02
SE9904750D0 (sv) 1999-12-23
AU1068101A (en) 2001-07-09
MY133485A (en) 2007-11-30
PE20011024A1 (es) 2001-10-03
WO2001047503A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
CO5190662A1 (es) Inhibidores altamente selectivos de la recaptacion de la norepinefrina y metodos de uso de los mismos
AR026371A1 (es) Nueva formulacion, uso y metodo
CU20150180A7 (es) Piridin-2 que contienen il-4-derivados sustituidos de 1-diazino fenilo útiles como ligandos de dopamina
NO20055208L (no) 4-(2-fenylsulfanyl-fenyl)-piperidinderivater som serotonin-reopptaksinhibitorer
AR077975A1 (es) Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
CO6640335A2 (es) Tratamiento terapéutico para síndrome metabólico, diabetes de tipo 2, obesidad o prediabetes
AR062841A1 (es) Tratamiento del dolor, diabetes, y trastornos del metabolismo de los lipidos
NI201500066A (es)
UY29613A1 (es) Compuestos quimicos vi
NI200700032A (es) Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas
EA200801488A1 (ru) Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью
NI201100117A (es) Antagonistas de 4 -- azetidinil - 1 - heteroaril - ciclohexanol del ccr2.
NO20061440L (no) Metode fo fremstilling av tiotropiumsalter og farmasoytiske formuleringer inneholdende samme.
NO20075153L (no) Terapeutisk anvendelse av nefopam og analoger derav
Krystal et al. Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
PE20040924A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
BRPI0408320A (pt) composto, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio afetivo
MXPA05010678A (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina.
DE60312874D1 (de) Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers
BRPI0407569A (pt) uso de s-10-hidróxi-10, 11-diidro-carbamazepina para o tratamento de ansiendade e distúrbios bipolares
NO20085172L (no) 3-(1h-indol-3-yl)indan-1-ylaminderivater for behandlingen av depresjon og angst
ATE423772T1 (de) Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
EA201070736A1 (ru) 4-[2,3-дифтор-6-(2-фтор-4-метилфенилсульфанил)фенил]пиперидин
AR039723A1 (es) Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina
AR048134A1 (es) La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial

Legal Events

Date Code Title Description
FB Suspension of granting procedure